Tag: drug development
-
Oncosyne Expands Pancreatic Cancer Patient Cohort to Strengthen Translational Research
Oncosyne has expanded the clinical study within the INVICTA project to include both chemotherapy-naïve and chemotherapy-treated patients with pancreatic cancer. The expanded study broadens the diversity of patient samples available for research and accelerates the growth of a clinically and molecularly annotated biobank of patient-derived pancreatic cancer tumoroids. Developed in collaboration with Sahlgrenska University Hospital…
-
Oncosyne at ESMO Targeted Anticancer Therapies Congress 2026 in Paris 🇫🇷
Oncosyne presented new research at ESMO TAT 2026 showing how patient-derived tumoroid models can support predictive biomarker discovery and strengthen decision-making in early oncology drug development. In the poster, Spatial pharmacoproteomics analysis of patient-derived tumoroids from colorectal cancer to identify predictive biomarkers, the team demonstrated how combining functional drug testing with high-content spatial analysis generates deeper…